Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan
TOKYO, Nov 20, 2024 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. announced today that the amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection25 mg” (mecobalamin) has been launched in Japan as a treatment for slowing progression of functionalimpairment in amyotrophic lateral sclerosis. The product received manufacturing and marketing approval in Japan on September […]